Showing results (251-260 of 323) with videos related to

Sort By:
Pageof 33
Neuroscience Letters|June 23, 2024
Loss of Slc35a2 alters development of the mouse cerebral cortexSoad Elziny, Sahibjot Sran, Hyojung Yoon, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Loss of <i>Slc35a2</i> alters development of the mouse cerebral cortexSoad Elziny, Sahibjot Sran, Hyojung Yoon, et al.
International Journal of Molecular Sciences|April 3, 2021
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro ModelsElisa Baldelli, Mahalakshmi Subramanian, Abduljalil M Alsubaie, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
SLC35A2 loss of function variants affect glycomic signatures, neuronal fate, and network dynamicsDulcie Lai, Paulina Sosicka, Damian J Williams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 3, 2007
EGFR and HER2 gene copy number and response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)Federico Cappuzzo, Claudia Ligorio, Claudio Ligorio, et al.
Brain Pathology (Zurich, Switzerland)|July 19, 2012
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammationAvanita S Prabowo, Jasper J Anink, Martin Lammens, et al.
Brain : a Journal of Neurology|May 26, 2025
SLC35A2 loss-of-function variants affect glycomic signatures, neuronal fate and network dynamicsDulcie Lai, Paulina Sosicka, Damian J Williams, et al.
Neurology|April 17, 2015
Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTORRichard J Leventer, Thomas Scerri, Ashley P L Marsh, et al.
Cold Spring Harbor Molecular Case Studies|September 3, 2017
Somatic uniparental disomy of Chromosome 16p in hemimegalencephalyNicole G Griffin, Kenneth D Cronin, Nicole M Walley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitorsJ-C Soria, F A Shepherd, J-Y Douillard, et al.
Pageof 33